Aetna’s Generic Gleevec Approach Combines Specialty Tiering, ‘Fail First’ Strategy
Executive Summary
Aetna oncology exec Kolodziej says the insurer expects the price discount for generic imatinib compared to the brand will be relatively modest at first.
You may also be interested in...
CVS Expands Formulary Exclusions In 2017, Express Scripts’ Tally Unchanged
National formulary exclusions continue in 2017, with CVS aggressively expanding its list of “not covered” drugs. Express Scripts currently excludes slightly fewer drugs than last year but may still add to its list.
CVS Expands Formulary Exclusions In 2017, Express Scripts’ Tally Unchanged
National formulary exclusions continue in 2017, with CVS aggressively expanding its list of “not covered” drugs. Express Scripts currently excludes slightly fewer drugs than last year but may still add to its list.
US Government Drug Pricing ‘Negotiation:’ Where We Go From Here
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: